Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.
Quick Facts
What This Study Found
Combined MSC and exendin-4 treatment produced beta cells with higher PDX-1, MafA, FoxO1, and GLP-1R expression and better glucose-stimulated insulin secretion than MSC alone in STZ-diabetic rats.
Key Numbers
40 rats; 5 groups; MSC+Ex4 significantly higher PDX-1, MafA, FoxO1, GLP-1R; increased insulin secretion; more insulin+/glucagon+ cells; no proliferation/apoptosis difference
How They Did This
Animal study. 40 male Sprague-Dawley rats in 5 groups (normal, DM, MSC, Ex4, MSC+Ex4). Assessed glucose tolerance, insulin secretion, immunofluorescence for insulin/glucagon/transcription factors, and proliferation/apoptosis markers.
Why This Research Matters
Regenerating functional beta cells is the holy grail of diabetes treatment. This study shows that GLP-1 analogs can enhance the quality of stem cell-derived beta cells, potentially making regenerative therapies more effective.
What This Study Doesn't Tell Us
Animal study in chemically induced diabetes, which differs from human type 1 or type 2 diabetes. Short-term study. Stem cell therapy is not yet practical for routine diabetes treatment. The mechanism by which exendin-4 improves transcription factor expression needs clarification.
Trust & Context
- Original Title:
- Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.
- Published In:
- Stem cells and development, 30(9), 502-514 (2021)
- Authors:
- Song, Xiaoyan, Sun, Xiaoya, Hao, Haojie, Han, Qingwang, Han, Weidong, Mu, Yiming
- Database ID:
- RPEP-05782
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05782APA
Song, Xiaoyan; Sun, Xiaoya; Hao, Haojie; Han, Qingwang; Han, Weidong; Mu, Yiming. (2021). Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.. Stem cells and development, 30(9), 502-514. https://doi.org/10.1089/scd.2020.0137
MLA
Song, Xiaoyan, et al. "Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.." Stem cells and development, 2021. https://doi.org/10.1089/scd.2020.0137
RethinkPeptides
RethinkPeptides Research Database. "Combined Treatment with Bone Marrow-Derived Mesenchymal Stem..." RPEP-05782. Retrieved from https://rethinkpeptides.com/research/song-2021-combined-treatment-with-bone
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.